Obligatory requirement for antibody in recovery from a primary poxvirus infection
about
Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infectionEvidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naïve MiceAdverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virusCritical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpoxImmune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected miceHuman CD4+ T cell epitopes from vaccinia virus induced by vaccination or infectionA role for NKG2D in NK cell-mediated resistance to poxvirus disease.Surviving mousepox infection requires the complement systemA method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.The poxvirus A35 protein is an immunoregulatorEfficacy of ST-246 versus lethal poxvirus challenge in immunodeficient miceThe immunology of smallpox vaccines.Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.A quantitative rabbit model of vaccinia keratitis.A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in ChinaAge-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and traffickingProtective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.Smallpox vaccines: targets of protective immunity.Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switchingVaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Cowpox virus induces interleukin-10 both in vitro and in vivoImmune modulation in primary vaccinia virus zoonotic human infectionsInhibition of cowpox virus and monkeypox virus infection by mitoxantrone.Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infectionPerforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection.Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicityLoss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.Correlates of protective immunity in poxvirus infection: where does antibody stand?Evolutionary struggles between NK cells and viruses.Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaquesIncreased per cell IFN-gamma productivity indicates recent in vivo activation of T cells.The smallpox vaccine induces an early neutralizing IgM response.Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.Defending against smallpox: a focus on vaccines.Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses.Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.Serologic and Molecular Evidence of Vaccinia Virus Circulation among Small Mammals from Different Biomes, Brazil.
P2860
Q27313373-DE7CBFC7-C521-43F4-BBDB-B1B8F96937D8Q27316583-28A2E429-2C2F-4626-B506-EFC681BFB7BFQ27346800-2B28DDAF-1FA4-4A74-843D-81A981F94503Q27346933-B8B4BF05-B139-421C-8138-FAF712D10F8BQ28748570-81C0B801-DF37-4577-9E38-DCAEC721D9C7Q33302672-34D504FB-BE15-4F9A-83B9-6AB5808F1AB5Q33319278-5711B1B8-E1A7-4203-81DC-58750C02D05EQ33396210-866AF314-D9C8-48A7-8A83-2708843926ABQ33429965-6BA97761-5A35-4869-A2ED-993FAC1A93A3Q33558734-EF81887F-B080-453F-872A-72521235D87FQ33639966-AEEE5C39-336F-469F-B828-627BD7F70E7CQ33679943-56860F5E-8AD2-444E-B949-250AC810534CQ34120177-74426297-F417-4358-9E10-D3F5FDD85601Q34135490-A8BCF5C3-276E-4948-A666-DFD151DED733Q34206208-0B476AFE-9352-472E-90BB-220E34981EB4Q34243319-6BB7823B-4D30-4F70-9124-B132990A047CQ34716960-855850E9-678E-42DF-A0A2-A034A42A7DBFQ34742613-B8FFF6D4-D88B-42AB-98A7-C708D03AC89AQ34780607-41F30D2B-E3CB-43B8-A8A8-0011A020B1ECQ34810232-274A7359-D3FF-42EF-8060-2ED9CB135D9DQ34991389-B410C9E6-097E-471B-A9C1-A3D363474AB1Q35206861-066C967B-76ED-4E31-AFDE-37AEE9286F01Q35539329-F67B1BE9-8F20-44F6-A53E-D8E29AF64B86Q35645804-670AA1B5-2614-4055-8082-C61732A9EB03Q35738585-4C2CFF32-EB38-417F-AD28-FA241438CED6Q35784998-7A16EE03-1C1E-47EE-9603-6B4D20EDFBEBQ36056478-5F3BC434-DB8D-402A-A21B-4540DCF92242Q36155548-4D4C3542-6B70-4914-8E57-60B37463BA0DQ36155569-3D857089-5F16-44B0-BBDB-C9AF7E51BEB1Q36965655-24F21A80-8717-44D8-B756-7022B698CF9EQ36976220-5B73E283-659C-4AFC-8F05-5D4E44D60F3DQ37107609-D8BFE665-F822-43FA-A72F-D057418A3187Q37211164-5BC3538C-C0DB-4D66-824D-8307C201761FQ37251764-EA62C1F9-A3A3-4489-B221-26593724FCE3Q37456873-EF1AF579-CDB8-4179-BBAC-52457E1F4E02Q37791160-51D5387A-3BEF-4333-9466-844C9C7098FBQ38799357-8AB79838-D585-41A5-93CC-AD79DAA02CBAQ39667525-B2ADDF2A-21AC-4323-B0AF-0A08A9A85758Q39916149-04C898CC-680A-4DA3-999D-1E1A50641AAFQ40197144-ACFD6922-CF92-4C37-B009-070A760B2EC1
P2860
Obligatory requirement for antibody in recovery from a primary poxvirus infection
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@ast
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@en
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@nl
type
label
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@ast
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@en
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@nl
prefLabel
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@ast
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@en
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@nl
P2093
P2860
P356
P1433
P1476
Obligatory requirement for antibody in recovery from a primary poxvirus infection
@en
P2093
Geeta Chaudhri
Gunasegaran Karupiah
Horst Bluethmann
Vijay Panchanathan
P2860
P304
P356
10.1128/JVI.00116-06
P407
P577
2006-07-01T00:00:00Z